Cargando…

Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates

Complement is an essential component of the innate and acquired immune system1, and consists of a series of proteolytic cascades that are initiated by the presence of micro-organisms. In health, activation of complement is precisely controlled through membrane-bound and soluble plasma-regulatory pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Muriel C., Prosser, Beverly E., Caesar, Joseph J.E., Kugelberg, Elisabeth, Li, Su, Zhang, Qian, Quoraishi, Sadik, Lovett, Janet E., Deane, Janet E., Sim, Robert B., Roversi, Pietro, Johnson, Steven, Tang, Christoph M., Lea, Susan M.
Formato: Texto
Lenguaje:English
Publicado: 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670278/
https://www.ncbi.nlm.nih.gov/pubmed/19225461
http://dx.doi.org/10.1038/nature07769
Descripción
Sumario:Complement is an essential component of the innate and acquired immune system1, and consists of a series of proteolytic cascades that are initiated by the presence of micro-organisms. In health, activation of complement is precisely controlled through membrane-bound and soluble plasma-regulatory proteins including factor H (fH)2, a 155 kDa protein composed of twenty domains (termed complement control protein repeats, or CCPs). Many pathogens have evolved the ability to avoid immune- killing by recruiting host complement regulators3 and several pathogens have adapted to avoid complement-mediated killing by sequestering fH to their surface4. Here we present the first structure of a complement regulator in complex with its pathogen surface-protein ligand. This reveals how the important human pathogen Neisseria meningitidis subverts immune responses by mimicking the host, using protein instead of charged-carbohydrate chemistry to recruit the host complement regulator, factor H. The structure also indicates the molecular basis of the host-specificity of the interaction between factor H and the meningococcus, and informs attempts to develop novel therapeutics and vaccines.